- This event has passed.
Meet Industry Leaders: Roche Venture Fund
September 27, 2017 @ 4:30 PM - 6:30 PM
A unique opportunity to hear from Karl Handelsman, Investment Director of Roche Venture Fund on lessons learned from a venture capitalist investing in early stage pre-clinical therapeutic companies. Their mission: “The Roche Venture Fund invests to develop commercially successful innovative life science companies.” The fund is a CHF 500 million evergreen fund that invests in life science companies in both pharmaceuticals and diagnostics with a focus on financial returns. Their offices are located in Basel, Switzerland and San Francisco.
His speech topic will be “Winning Strategies for Biotech Startups”. He will discuss the strategies companies deploy to cross the “Valley of Death” to build value. He will also cover some of the destructive myths about biotech and venture.
Karl Handelsman has been a biotech venture investor for 18 years, prior to that he worked in business development at two biotech startups that were each acquired for billions.
Date: Wednesday September 27, 2017
Time: 4:30pm to 6:30pm
Location: Main floor lecture theatre, BC Cancer Agency Research Centre, 675 West 10th Avenue, Vancouver, BC
For more information please contact:
Ryan Butt, Manager Events & Outreach
Phone: 604 669-9909 ext. 104 & Email: firstname.lastname@example.org